Operating Lease, Right-of-Use Asset of C4 Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
C4 Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • C4 Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $41,961,000, a 29% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $41,961,000 -$17,206,000 -29% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $54,218,000 -$6,563,000 -11% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $55,886,000 -$6,491,000 -10% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $57,536,000 -$6,420,000 -10% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $59,167,000 -$6,353,000 -9.7% 30 Sep 2024 10-Q 31 Oct 2024 2023 Q1
Q2 2024 $60,781,000 -$6,286,000 -9.4% 30 Jun 2024 10-Q 01 Aug 2024 2023 Q1
Q1 2024 $62,377,000 -$6,222,000 -9.1% 31 Mar 2024 10-Q 08 May 2024 2023 Q1
Q4 2023 $63,956,000 -$6,160,000 -8.8% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $65,520,000 -$6,098,000 -8.5% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q1
Q2 2023 $67,067,000 -$6,055,000 -8.3% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q1
Q1 2023 $68,599,000 -$6,229,000 -8.3% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $70,116,000 +$38,171,000 +119% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $71,618,000 +$59,369,000 +485% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $73,122,000 +$60,540,000 +481% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $74,828,000 +$61,919,000 +480% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $31,945,000 +$18,716,000 +141% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 $12,249,000 -$1,295,000 -9.6% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $12,582,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $12,909,000 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $13,229,000 -$1,224,000 -8.5% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $13,544,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 $14,453,000 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.